iBio
IBIO
#9866
Rank
NZ$75.37 M
Marketcap
NZ$3.35
Share price
-19.83%
Change (1 day)
-17.69%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): NZ-$3.86

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$3.94. In 2024 the company made an earnings per share (EPS) of NZ-$11.23 an increase over its 2023 EPS that were of NZ-$183.48.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$3.86-65.63%
2024NZ-$11.23-93.88%
2023NZ-$183.48-8.14%
2022NZ-$199.7392.67%
2021NZ-$103.67-80.33%
2020NZ-$526.98-35.11%
2019NZ-$812.07-38.96%
2018NZ-$1,330-6.1%
2017NZ-$1,41736.67%
2016NZ-$1,03733.33%
2015NZ-$777.5150%
2014NZ-$518.34-53.85%
2013NZ-$1,123-7.14%
2012NZ-$1,209-64.1%
2011NZ-$3,36977.27%
2010NZ-$1,901144.44%
2009NZ-$777.5112.93%
2008NZ-$688.5012.2%
2007NZ-$613.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Genocea Biosciences
GNCA
NZ-$0.90-77.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.44-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.04-557.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$7.31 85.53%๐Ÿ‡บ๐Ÿ‡ธ USA